KYMR
Price
$22.34
Change
-$1.35 (-5.70%)
Updated
Apr 4, 02:42 PM (EDT)
Capitalization
1.71B
27 days until earnings call
OMER
Price
$7.07
Change
-$0.29 (-3.94%)
Updated
Apr 4, 04:53 PM (EDT)
Capitalization
427.06M
39 days until earnings call
Ad is loading...

KYMR vs OMER

Header iconKYMR vs OMER Comparison
Open Charts KYMR vs OMERBanner chart's image
Kymera Therapeutics
Price$22.34
Change-$1.35 (-5.70%)
Volume$100
Capitalization1.71B
Omeros
Price$7.07
Change-$0.29 (-3.94%)
Volume$1.99K
Capitalization427.06M
KYMR vs OMER Comparison Chart
Loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OMER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYMR vs. OMER commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Hold and OMER is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (KYMR: $23.69 vs. OMER: $7.36)
Brand notoriety: KYMR and OMER are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 113% vs. OMER: 215%
Market capitalization -- KYMR: $1.71B vs. OMER: $427.06M
KYMR [@Biotechnology] is valued at $1.71B. OMER’s [@Biotechnology] market capitalization is $427.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileOMER’s FA Score has 1 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • OMER’s FA Score: 1 green, 4 red.
According to our system of comparison, OMER is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 4 TA indicator(s) are bullish while OMER’s TA Score has 5 bullish TA indicator(s).

  • KYMR’s TA Score: 4 bullish, 4 bearish.
  • OMER’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both KYMR and OMER are a good buy in the short-term.

Price Growth

KYMR (@Biotechnology) experienced а -21.56% price change this week, while OMER (@Biotechnology) price change was -17.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.29%. For the same industry, the average monthly price growth was -17.13%, and the average quarterly price growth was -18.92%.

Reported Earning Dates

KYMR is expected to report earnings on May 01, 2025.

OMER is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-11.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($1.71B) has a higher market cap than OMER($427M). OMER YTD gains are higher at: -25.506 vs. KYMR (-41.114). OMER has higher annual earnings (EBITDA): -155.96M vs. KYMR (-216.24M). KYMR has more cash in the bank: 489M vs. OMER (123M). KYMR has less debt than OMER: KYMR (87.8M) vs OMER (209M). KYMR has higher revenues than OMER: KYMR (47.1M) vs OMER (0).
KYMROMERKYMR / OMER
Capitalization1.71B427M401%
EBITDA-216.24M-155.96M139%
Gain YTD-41.114-25.506161%
P/E RatioN/AN/A-
Revenue47.1M0-
Total Cash489M123M398%
Total Debt87.8M209M42%
FUNDAMENTALS RATINGS
OMER: Fundamental Ratings
OMER
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
11
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KYMROMER
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 19 days ago
85%
Bullish Trend 16 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 4 days ago
79%
View a ticker or compare two or three
Ad is loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OMER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SCRUX10.84N/A
N/A
Invesco Income Advantage U.S. Fund R
JCICX72.41N/A
N/A
JPMorgan U.S. GARP Equity C
DCZRX28.51N/A
N/A
Macquarie Small Cap Core R6
AGFGX11.21N/A
N/A
American Century Focused Global Gr R5
PLIEX28.14N/A
N/A
Plumb Equity Institutional

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with CCCC. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-10.13%
CCCC - KYMR
59%
Loosely correlated
-9.54%
RCKT - KYMR
51%
Loosely correlated
-11.75%
ATXS - KYMR
51%
Loosely correlated
-6.70%
IMNM - KYMR
50%
Loosely correlated
-7.00%
NRIX - KYMR
50%
Loosely correlated
-7.64%
More